In summary, our study indicated that ddPCR can be used for plasma cfDNA EGFR mutation detection, and plasma cfDNA EGFR mutation analysis could be an effective supplemental test for tumor-tissue EGFR M- patients. Here, EGFR is linked to neoplasm.